These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20107035)

  • 1. Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry.
    Nocturne G; Dougados M; Constantin A; Richez C; Sellam J; Simon A; Wendling D; Mariette X; Gottenberg JE
    Ann Rheum Dis; 2010 Feb; 69(2):471-2. PubMed ID: 20107035
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments in the therapy of spondyloarthropathies.
    Stone M; Inman RD
    Curr Rheumatol Rep; 2000 Aug; 2(4):279-81. PubMed ID: 11123071
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of patients with spondyloarthropathies for treatment with tumour necrosis factor alpha blockade.
    Paul S; Keat A
    Rheumatology (Oxford); 2005 Jan; 44(1):17-23. PubMed ID: 15328421
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab in refractory spondyloarthropathies: a multicentre 38 week open study.
    Collantes-Estévez E; Muñoz-Villanueva MC; Cañete-Crespillo JD; Sanmartí-Sala R; Gratacós-Masmitjá J; Zarco-Montejo P; Torre-Alonso JC; González-Fernández C
    Ann Rheum Dis; 2003 Dec; 62(12):1239-40. PubMed ID: 14644870
    [No Abstract]   [Full Text] [Related]  

  • 5. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009.
    Furst DE; Keystone EC; Fleischmann R; Mease P; Breedveld FC; Smolen JS; Kalden JR; Braun J; Bresnihan B; Burmester GR; De Benedetti F; Dörner T; Emery P; Gibofsky A; Kavanaugh A; Kirkham B; Schiff MH; Sieper J; Singer N; Van Riel PL; Weinblatt ME; Weisman MH; Winthrop K
    Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i2-29. PubMed ID: 19995740
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biotherapies: toward a second revolution?].
    Mouthon L
    Presse Med; 2009 May; 38(5):746-8. PubMed ID: 19328647
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of psoriatic arthritis with rituximab.
    Cohen JD
    Ann Rheum Dis; 2008 Nov; 67(11):1647-8. PubMed ID: 18854517
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
    Dahlin J; Sørensen SF
    Ugeskr Laeger; 2003 Nov; 165(48):4646-9. PubMed ID: 14677464
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab as a treatment alternative in sarcoidosis.
    Belkhou A; Younsi R; El Bouchti I; El Hassani S
    Joint Bone Spine; 2008 Jul; 75(4):511-2. PubMed ID: 18562234
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab: a new therapeutic alternative in rheumatoid arthritis.
    Sibilia J; Gottenberg JE; Mariette X
    Joint Bone Spine; 2008 Oct; 75(5):526-32. PubMed ID: 18571968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biologicals in the treatment of rheumatic diseases].
    Scherer HU; Burmester GR
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2279-85. PubMed ID: 17036270
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab in rheumatic diseases.
    Saraux A; Devauchelle V; Jousse S; Youinou P
    Joint Bone Spine; 2007 Jan; 74(1):4-6. PubMed ID: 17178461
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful use of infliximab in a patient with treatment resistant spondyloarthropathy related uveitis.
    Kruithof E; Kestelyn P; Elewaut C; Elewaut D; Van Den Bosch F; Mielants H; Veys EM; De Keyser F
    Ann Rheum Dis; 2002 May; 61(5):470. PubMed ID: 11959776
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry).
    Glace B; Gottenberg JE; Mariette X; Philippe R; Pereira B; Lequerré T; Berthelot JM; Dougados M; Toussirot E; Pham T; Allanore Y; Loeuille D; Euller-Ziegler L; Soubrier M
    Ann Rheum Dis; 2012 Aug; 71(8):1429-31. PubMed ID: 22504557
    [No Abstract]   [Full Text] [Related]  

  • 15. Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate.
    Cohen SB; Keystone E; Genovese MC; Emery P; Peterfy C; Tak PP; Cravets M; Shaw T; Hagerty D
    Ann Rheum Dis; 2010 Jun; 69(6):1158-61. PubMed ID: 20439295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients.
    Genovese MC; Breedveld FC; Emery P; Cohen S; Keystone E; Matteson EL; Baptiste Y; Chai A; Burke L; Reiss W; Sweetser M; Shaw TM
    Ann Rheum Dis; 2009 Dec; 68(12):1894-7. PubMed ID: 19155233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in Graves' disease.
    Rodien P
    Eur J Endocrinol; 2008 Nov; 159(5):515-6. PubMed ID: 18708435
    [No Abstract]   [Full Text] [Related]  

  • 18. Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.
    Prescrire Int; 2009 Oct; 18(103):198-201. PubMed ID: 19882783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tendency towards erosive regression on magnetic resonance imaging at 12 months in rheumatoid arthritis patients treated with rituximab.
    Døhn UM; Ostergaard M; Bird P; Boonen A; Johansen JS; Møller JM; Hansen MS
    Ann Rheum Dis; 2009 Jun; 68(6):1072-3. PubMed ID: 19435723
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful response to infliximab in a patient with undifferentiated spondyloarthropathy coexisting with polyarteritis nodosa-like cutaneous vasculitis.
    Garcia-Porrua C; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S138. PubMed ID: 14740443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.